CARLSBAD, Calif., Dec. 11, 2018 /PRNewswire/ — ChromaCode, Inc., a company redefining molecular testing through data science, today announced the commercial launch of its first-ever multiplex test using the […]
CARLSBAD, Calif – The popular business and marketing intelligence resource MedTech Strategist published an overview article in their May 29th issue titled, “ChromaCode Disrupts Molecular Diagnostics […]
CARLSBAD, Calif – ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Series B funding. This latest round is led by […]